v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 96,473 $ 91,499
Accounts receivable, net 143,907 165,516
Inventory, net 42,299 49,333
Other current assets and prepaid expenses 35,052 42,513
Total current assets 317,731 348,861
Property, plant and equipment, net 144,674 146,557
Intangible assets, net 614,452 683,835
In-process research and development 635,572 647,347
Goodwill 700,193 717,099
Investments 31,228 40,642
Other assets 7,222 5,615
Total assets 2,451,072 2,589,956
Current liabilities:    
Accounts payable 47,395 74,307
Accrued expenses 203,513 225,796
Current portion of 2033 Senior Notes 31,562 0
Current portion of lines of credit and notes payable 5,851 11,926
Total current liabilities 288,321 312,029
2023 Convertible Notes and 2033 Senior Notes 57,299 29,160
Deferred tax liabilities, net 115,193 148,729
Other long-term liabilities, principally contract liabilities, contingent consideration and lines of credit 198,968 256,415
Total long-term liabilities 371,460 434,304
Total liabilities 659,781 746,333
Equity:    
Common Stock - $0.01 par value, 750,000,000 shares authorized; 586,881,720 and 560,023,745 shares issued at December 31, 2018 and 2017, respectively 5,869 5,600
Treasury Stock, at cost - 549,907 shares at December 31, 2018 and 2017, respectively (1,791) (1,791)
Additional paid-in capital 3,004,422 2,889,256
Accumulated other comprehensive income (loss) (20,131) (528)
Accumulated deficit (1,197,078) (1,048,914)
Total shareholders’ equity 1,791,291 1,843,623
Total liabilities and equity $ 2,451,072 $ 2,589,956

Source